€16.34
0.62% today
Xetra, Sep 16, 05:35 pm CET
ISIN
DE000A1MMCC8
Symbol
ILM1
Index

Medios Stock price

€16.34
-0.10 0.61% 1M
+2.46 17.72% 6M
+0.48 3.03% YTD
+1.60 10.85% 1Y
-21.36 56.66% 3Y
-0.81 4.72% 5Y
+8.84 117.87% 10Y
Xetra, Closing price Mon, Sep 16 2024
+0.10 0.62%
ISIN
DE000A1MMCC8
Symbol
ILM1
Index
Sector

Key metrics

Market capitalization €414.21m
Enterprise Value €570.99m
P/E (TTM) P/E ratio 24.33
EV/FCF (TTM) EV/FCF 4.70
EV/Sales (TTM) EV/Sales 0.31
P/S ratio (TTM) P/S ratio 0.23
P/B ratio (TTM) P/B ratio 0.82
Revenue growth (TTM) Revenue growth 9.95%
Revenue (TTM) Revenue €1.84b
EBIT (operating result TTM) EBIT €28.63m
Free Cash Flow (TTM) Free Cash Flow €121.59m
Cash position €81.69m
EPS (TTM) EPS €0.67
P/E forward 15.67
P/S forward 0.21
EV/Sales forward 0.29
Show more

Is Medios a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

Medios Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Medios forecast:

6x Buy
100%

Analyst Opinions

6 Analysts have issued a Medios forecast:

Buy
100%

Financial data from Medios

Jun '24
+/-
%
Net Profit 16 16
9% 9%
1%
Depreciation and Amortization 22 22
2% 2%
1%
Stock Compensation - -
-
-
Operating Cash Flow 124 124
349% 349%
7%
Investments 2.50 2.50
9% 9%
0%
Dividend Paid - -
-
-
Free Cash Flow 122 122
334% 334%
7%

In millions EUR.

Don't miss a Thing! We will send you all news about Medios directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Medios Stock News

EQS
about one month ago
Die Aktionärinnen und Aktionäre stimmten einer Erweiterung des Aufsichtsrats von vier auf fünf Mitglieder zu. Nachdem Klaus J. Buß sein Amt niederlegte, wurden Herr Florian Herger (Diplom-Kaufmann und Investmentmanager (Principal) bei der Luxempart S.A) und Herr Jens Apermann (selbständiger Berat...
EQS
about one month ago
Matthias Gärtner, Vorstandsvorsitzender (CEO) der Medios AG: „Im Fokus des ersten Halbjahres 2024 stand der erfolgreiche Abschluss der Ceban-Akquisition – einer der wichtigsten Meilensteine auf unserem Weg zur Transformation in eine Europäische Specialty-Pharma-Plattform. Die konsequente Umsetzun...
EQS
about one month ago
Berlin, 5. August 2024 – Die Medios AG („Medios“), ein führender Anbieter von Specialty Pharma in Europa, verstärkt seine Aktivitäten im Bereich „Advanced Therapies“ und ernennt in diesem Zuge Dr. Andreas Schmiede zum Vice President Advanced Therapies. Der Eintritt in den Markt für Neuartige Ther...
More Medios News

Company Profile

Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. It operates through the following segments: Provision of Medicinal Products, Patient-specific Therapies, and Services. The Provision of Medicinal Products segment focuses on specialty pharmaceuticals means it trades almost exclusively in expensive medicinal products for chronic and/or rare diseases. The Patient-specific Therapies segment include infusions constituted and produced on the basis of individual symptoms and individual parameters such as body weight and body surface. The Services segment consists of all other Group activities, including Medios Group holding activities. The company was founded in 1980 and is headquartered in Berlin, Germany.

Head office Germany
CEO Matthias Gärtner
Employees 515
Founded 1980
Website www.medios.ag

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today